Scorpio Bulkers Inc (SALT) Jumps 10.24% on February 22

Equities Staff |

Scorpio Bulkers Inc (SALT) was among the biggest gainers on the Russell 2000 for Monday February 22 as the stock popped 10.24% to $2.26, representing a gain of $0.21 per share. Some 246,430 shares traded hands on 1,227 trades, compared with an average daily volume of 317,381 shares out of a total float of 2.39 million. The stock opened at $2.10 and traded with an intraday range of $2.30 to $2.08.

After today's gains, Scorpio Bulkers Inc reached a market cap of $5.4 million. Scorpio Bulkers Inc has had a trading range between $35.39 and $1.79 over the last year, and it had a 50-day SMA of $5.29 and a 200-day SMA of $16.37.

Scorpio Bulkers Inc is engaged in acquiring and operating newbuilding drybulk carriers with fuel-efficient specifications and carrying capacities of greater than 30,000 dwt in the international shipping markets. It owns two Kamsarmax vessels.

Scorpio Bulkers Inc is based out of Monaco, and has some 3 employees. Its CEO is Emanuele A. Lauro.

For a complete fundamental analysis analysis of Scorpio Bulkers Inc, check out’s Stock Valuation Analysis report for SALT. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets


Cloudera offers enterprises a new data platform built on the Apache Hadoop open-source software package. Hadoop is a data-management platform that can consolidate data in a single repository for comprehensive…


Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…